Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The Prostate

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0045(19980701)36:2<71::AID-PROS1>3.0.CO;2-HPMID 9655258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma

  2005cited by this paper
• Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration

  2004cited by this paper
• Expression of transforming growth factor-β receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment

  2004cited by this paper
• Testosterone Stimulates Angiogenesis and Vascular Regrowth in the Ventral Prostate in Castrated Adult Rats.

  1998cited by this paper
• Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats.

  1998cited by this paper
• Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Vascular endothelial growth factor expression is increased in renal cell carcinoma.

  1997cited by this paper
• Effect of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium.

  1997cited by this paper
• Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.

  1997cited by this paper
• Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.

  1997cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Growth factors in angiogenesis: current interest and therapeutic potential.

  1997cited by this paper
• Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

  1997cited by this paper
• Vascular density is a predictor of cancer‐specific survival in prostatic carcinoma

  1997cited by this paper
• Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells.

  1996cited by this paper
• Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.

  1996cited by this paper
• Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma.

  1996cited by this paper
• Expression of transforming growth factor‐βI in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment

  1996cited by this paper
• Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.

  1996cited by this paper
• Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.

  1996cited by this paper
• Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

  1996cited by this paper
• Quantitative analysis of vascular endothelial growth factor in primary breast cancer

  1996cited by this paper
• Angiostatin induces and sustains dormancy of human primary tumors in mice

  1996cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

  1995cited by this paper
• The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis.

  1995cited by this paper
• Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.

  1995cited by this paper
• Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies.

  1995cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen.

  1995cited by this paper
• Angiogenesis in urological malignancy.

  1995cited by this paper
• Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.

  1995cited by this paper
• Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

  1994cited by this paper
• Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.

  1994cited by this paper
• Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.

  1994cited by this paper
• A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).

  1994cited by this paper
• Vascular endothelial growth factor and its receptors.

  1994cited by this paper
• Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells.

  1994cited by this paper
• Vascular permeability factor, tumor angiogenesis and stroma generation.

  1994cited by this paper
• Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.

  1993cited by this paper
• Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated dunning R3327 prostatic adenocarcinoma

  1993cited by this paper
• A rapid and versatile method to synthesize internal standards for competitive PCR.

  1993cited by this paper
• Antiangiogenic effects of the quinoline-3-carboxamide linomide.

  1993cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• Androgen regulation of programmed death of normal and malignant prostatic cells.

  1992cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

  1992cited by this paper
• Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study

  1992cited by this paper
• The role of angiogenesis in tumor growth.

  1992cited by this paper
• Characterization of the human cyclophilin gene and of related processed pseudogenes.

  1990cited by this paper
• Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

  1990cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Activation of programmed cell death in the rat ventral prostate after castration.

  1988cited by this paper
• pl Bl5: A cDNA Clone of the Rat mRNA Encoding Cyclophilin

  1988cited by this paper
• Cellular response to androgen depletion and repletion in the rat ventral prostate: Autoradiography and morphometric analysis

  1985cited by this paper

• Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.

  2019cites this paper
• Angiogenic and Tissue Remodeling Factors in the Prostate of Elderly Rats Submitted to Hormonal Replacement

  2013cites this paper
• Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma

  2012cites this paper
• Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang‐2

  2012cites this paper
• Prostate Cancer Diagnosis : experimental and Clinical Studies With HRMAS NMR Spectroscopy

  2011cites this paper
• Targeting castration‐induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model

  2011cites this paper
• Detection of Local Prostate Metabolites by Hrmas Nmr Spectroscopy: A Comparative Study of Human and Rat Prostate Tissues:

  2010cites this paper
• Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target

  2009influential citation
• Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target.

  2009cites this paper
• Androgen Controlled Regulatory Systems in Prostate Cancer -Potential new therapeutic targets and prognostic markers

  2008cites this paper
• Differential expression of angiopoietin‐2 and vascular endothelial growth factor in androgen‐independent prostate cancer models

  2008cites this paper
• Endothelial cells support the growth of prostate tissue in vivo

  2008cites this paper
• Phytoestrogens and prostate cancer : experimental, clinical, and epidemiological studies

  2007cites this paper
• A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model

  2007cites this paper
• Inhibitory Effects of Castration in an Orthotopic Model of Androgen-Independent Prostate Cancer Can Be Mimicked and Enhanced by Angiogenesis Inhibition

  2006cites this paper
• Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats.

  2005cites this paper
• Identification of androgen‐responsive genes that are alternatively regulated in androgen‐dependent and androgen‐independent rat prostate tumors

  2005influential citation
• Vascular endothelial growth factor expression in untreated and androgen-deprived patients with prostate cancer.

  2005cites this paper
• Transition of an androgen‐dependent human prostate cancer cell line into an androgen‐independent subline is associated with increased angiogenesis

  2005cites this paper
• Role of androgen on blood flow and capillary structure in rat seminal vesicles.

  2004cites this paper
• Quantitative Proteomic Analysis of Proteins Released by Neoplastic Prostate Epithelium

  2004cites this paper
• Androgen receptor in prostate cancer.

  2004cites this paper
• Hormonal Regulation and Functional Role of Vascular Endothelial Growth Factor A in the Rat Testis1

  2004influential citation
• Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.

  2004cites this paper
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate.

  2004cites this paper
• Localized Expression of Angiopoietin 1 and 2 May Explain Unique Characteristics of the Rat Testicular Microvasculature1

  2003cites this paper
• Regulation of normal and malignant prostate cell biology by IGF-I: mechanisms and modulation by dietary polyphenols and energy restriction

  2003cites this paper
• Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma

  2003cites this paper
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration.

  2003cites this paper
• Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats

  2003cites this paper
• Prostate development and carcinogenesis.

  2003cites this paper
• Endothelial Cell Proliferation in Male Reproductive Organs of Adult Rat Is High and Regulated by Testicular Factors1

  2003cites this paper
• Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

  2002cites this paper
• Androgens modulate the balance between VEGF and angiopoietin expression in prostate epithelial and smooth muscle cells

  2002cites this paper
• Effects of Finasteride on Vascular Endothelial Growth Factor

  2002cites this paper
• Blood Vessels are Regulators of Growth, Diagnostic Markers and Therapeutic Targets in Prostate Cancer

  2001cites this paper
• Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver.

  2001cites this paper
• Angiogenesis and prostate cancer: identification of a molecular progression switch.

  2001cites this paper
• Castration‐induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancer

  2001cites this paper
• Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer.

  2001cites this paper
• Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum.

  2001cites this paper
• Basic science of hormonal therapy for prostate cancer.

  2001cites this paper
• Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue.

  2001cites this paper
• Role of Angiogenesis in the Progression and Treatment of Prostate Cancer

  2001cites this paper
• Accelerated Tumor Cell Death by Angiogenic Modifiers

  2001cites this paper
• Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells

  2000cites this paper
• Vascular endothelial growth factor content in metastasizing and nonmetastasizing dunning prostatic adenocarcinoma

  2000cites this paper
• Regulation of VEGF in the reproductive tract by sex-steroid hormones.

  2000cites this paper
• Effects of finasteride and bicalutamide on prostatic blood flow in the rat

  2000cites this paper
• Vascular endothelial growth factor‐A expression in the rat ventral prostate gland and the early effects of castration

  2000cites this paper
• Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.

  2000cites this paper
• The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression

  2000cites this paper
• Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity.

  1999cites this paper
• Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats.

  1999cites this paper
• Early effects of castration on the vascular system of the rat ventral prostate gland.

  1999cites this paper
• Targeting Angiogenic Pathways Involving Tumor–stromal Interaction to Treat Advanced Human Prostate Cancer

  1998cites this paper
• Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.

  1998cites this paper